The integration of AI-powered deep learning models into drug discovery revolutionized the pharmaceutical giant's R&D process, dramatically reducing time and costs. By accelerating the identification of viable drug candidates and contributing to the swift development of a COVID-19 vaccine candidate, AI proved to be a transformative force in pharmaceutical innovation. This case study highlights how embracing advanced technologies can not only enhance operational efficiency but also deliver life-saving solutions at unprecedented speeds.